Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain
- 1 April 2014
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 79, 119-126
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Mitochondrial Function and Energy Metabolism in Umbilical Cord Blood- and Bone Marrow-Derived Mesenchymal Stem CellsStem Cells and Development, 2011
- Transplantation of Marrow Stromal Cells Restores Cerebral Blood Flow and Reduces Cerebral Atrophy in Rats with Traumatic Brain Injury: In vivo MRI StudyJournal of Neurotrauma, 2011
- The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: Functional outcome and gene expression profileBrain Research, 2011
- Endothelial progenitor cell transplantation improves long‐term stroke outcome in miceAnnals of Neurology, 2010
- Safety and Tolerability of Cyclosporin A in Severe Traumatic Brain Injury Patients: Results from a Prospective Randomized TrialJournal of Neurotrauma, 2009
- Marrow stromal cell transplantation in stroke and traumatic brain injuryNeuroscience Letters, 2009
- An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathologyJournal of Neuroscience Methods, 2009
- Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult ratsBrain Research, 2008
- Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative settingBlood, 2006
- Intravenous Administration of Marrow Stromal Cells (MSCs) Increases the Expression of Growth Factors in Rat Brain after Traumatic Brain InjuryJournal of Neurotrauma, 2004